Catch by Gene has entered into a supply agreement with C&S Company, a producer of pharmaceuticals and medical equipment for physicians, to supply its reagent solutions for an initial amount of $300,000.

The supply contract between the two companies deals with Catch by Gene’s test kit products that identifies sexually transmitted diseases including the Human Papilloma Virus (HPV) at an early stage.

Catch by Gene is expected to begin supplying C&S 60,000 reagents a year and then anticipates increasing each year along with increased demand requirements in addition to other international distributors.

Catch by Gene claimed that the detection kit is a lower cost HPV test for the affluent populations which is now becoming available to the larger populations in Africa, Asia and Latin America.

Catch by Gene is devoted to the research, development, manufacture and marketing of advanced in-vitro nucleic acid assay with capture hybridisation assay with multi-probes using microplate chemiluminescense or colorimetry method for the direct detection of several infectious pathogens.